Description

Wiskott-Aldrich Syndrome (WAS) is a primary disorder of both cellular and humoral immunity associated with a defect in a protein involved in signal transduction affecting actin polymerization.


 

Inheritance: X-linked recessive

 

Genetic defect: defect in the gene for the WAS protein (WASP), localized to the short arm of the X chromosome (Xp11.23)

 

Clinical features:

(1) Most affected patients are males, with onset typically during infancy.

(2) There is an immune deficiency with recurrent infections which may be fulminant.

(2a) There is a failure to produce antibodies to polysaccharide antigens and there is a poor response to vaccinations.

(2b) There is a combined defect in cell-mediated immunity affecting both B and T cells.

(2c) Patients may have recurrent respiratory tract infections, otitits and/or diarrhea.

(2d) Patients may have infections with opportunistic pathogens such as pneumocystis pneumonia.

(2e) Viral infections may be severe and patients may develop infections following vaccination with live-virus vaccines.

(3) Most patients develop eczema.

(4) Patients may have a moderate to severe bleeding disorder.

(5) Patients have a predisposition to immune disorders.

(5a) autoimmune hemolytic disease (AIHD)

(5b) immune thrombocytopenia (ITP)

(5c) immune complex disorders

(6) Patients have a predisposition to malignancies, especially leukemia and lymphoma.

 

Laboratory features:

(1) There is a moderate to severe thrombocytopenia.

(2) Platelets are very small in size, and there is a marked decrease in total platelet volume.

(3) The bleeding time is prolonged.

(4) Platelet function is impaired due to a platelet storage pool defect.

(5) IgM levels are reduced. IgG may be reduced to normal. IgA and IgE may be increased.

(6) ABO antibodies may be weak or absent.

(7) T cells show impaired function and reduce response to mitogens.

(8) Lymphocytopenia may develop as the patient gets older.

(9) There are reduced microvillous projections on the surface of T lymphocytes.

 


To read more or access our algorithms and calculators, please log in or register.